via ResearchGate
In a pair of related studies, a team of Yale researchers has found a way to reverse type-2 diabetes and liver fibrosis in mice, and has shown that the underlying processes are conserved in humans.
The studies appear in the Feb. 4 edition of Cell Reports and in the Jan. 17 edition of Nature Communications.
In the earlier study, researchers found an important connection between how the body responds to fasting and type-2 diabetes. Fasting “switches on” a process in the body in which two particular proteins, TET3 and HNF4a, increase in the liver, driving up production of blood glucose. In type-2 diabetes, this “switch” fails to turn off when fasting ends, as it would in a non-diabetic person.
Researchers hypothesized that if they could “knock down” the levels of these two proteins, they could stop diabetes from developing. Yingqun Huang, M.D., Yale associate professor in Obstetrics, Gynecology, and Reproductive Sciences and her team injected mice with genetic material known as small interfering RNAs (siRNAs) packaged inside viruses that targeted TET3 or HNF4a. They found that blood glucose and insulin dropped significantly — effectively stopping diabetes in its tracks.
In the Feb. 4 Cell Reports study, researchers looked at how TET3 contributed to the development of fibrosis in the liver, and found that the protein was involved in fibrosis on multiple levels. Almost all fibrosis, regardless of the organ involved, starts from abnormal protein signaling, Huang said.
She and colleagues discovered that TET3 plays a role in the fibrosis signaling pathway in three different locations — and acts as an important regulator in fibrosis development. This means there are likely opportunities to develop drugs that inhibit TET3 to slow or reverse fibrosis, said Da Li, associate research scientist in genetics and co-author on both studies.
Both diseases — type-2 diabetes and fibrosis of the liver and other organs — are common, but have few treatment options. Around 28 million people in the U.S. have type-2 diabetes, characterized by high blood sugar levels, a condition that can lead to many other health problems, including heart disease, stroke, and kidney failure.
Cirrhosis is one of the leading causes of death worldwide and is marked by liver fibrosis — a buildup of scar tissue on the liver, said co-author James Boyer, M.D., professor and emeritus director of the Yale Liver Center.
Researchers noted that several drugs, such as metformin, are currently available to control blood sugar levels in patients with diabetes. But these have a range of unpleasant side effects, and patients can develop resistance to these drugs.
And there is little medical relief for fibrosis sufferers.
“Right now, there are no effective drugs for the treatment of fibrosis,” said Xuchen Zhang, M.D., associate professor in pathology and co-author on the fibrosis study.
Huang has filed for a patent related to her discoveries with support from the Yale Office of Cooperative Research.
The next step, she said, will be to identify where to best target TET3 and HNF4a and to develop the most effective siRNAs or small molecules to treat type-2 diabetes or fibrosis.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Reversing type-2 diabetes and liver fibrosis
- Celebration of a century of insulin therapy in children with type 1 diabetes
Insulin is the key anabolic hormone of metabolism, with clear effects on glycaemia. Near-complete insulin deficiency occurs in type 1 diabetes (T1D), the predominant form affecting children, and ...
- Type 2 Diabetes Risk Increases in Children with Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is the most common pediatric liver disease, affecting 5 to 8 million children in the United States. In NAFLD, the cells of the liver store large fat droplets, ...
- The Call for Advanced Therapy & Devices to Treat Hepatic Fibrosis
(Sun, 2020). This underscores the fact that there is a pressing need for new therapies to slow the progression of hepatic fibrosis or reverse it altogether. To duplicate the liver's natural function, ...
- Pediatric liver disease increases risk of developing type 2 diabetes
Nonalcoholic fatty liver disease (NAFLD) is the most common pediatric liver disease, affecting 5 to 8 million children in the United States. In NAFLD, the cells of the liver store large fat droplets, ...
- Risk of New-Onset Type 2 Diabetes Up After Cancer Diagnosis
Adults with a cancer diagnosis have increased incidence of new-onset type 2 diabetes, according to a research letter published online May 27 in ...
Go deeper with Google Headlines on:
Reversing type-2 diabetes and liver fibrosis
Go deeper with Bing News on:
Type-2 diabetes and liver fibrosis
- Risk for Existing, Incident T2D High in Children With NAFLD
Children with nonalcoholic fatty liver disease (NAFLD) have a high risk for existing and incident type 2 diabetes (T2D), with a prevalence of 16.8 percent, according to a study published online June ...
- Nonalcoholic Steatohepatitis Therapeutics Market Expands with Rising Cases of Obesity and Diabetes, States TMR Report
Rise in awareness on availability of nonalcoholic steatohepatitis therapeutics is creating revenue-generation opportunities in the marketWilmington, Delaware, United States, June 21, 2022 (GLOBE ...
- Study uncovers new treatment approaches for liver cancer patients
Experts from Cedars-Sinai Cancer have analyzed patient samples, along with studies conducted in animal models, to identify a novel immune checkpoint pathway to treat hepatocellular carcinoma, the most ...
- Fecal Transplant Durable in IBS; Growth Hormone for NAFLD? Drug Use and DAA Activity
Children with NAFLD have a higher risk for type 2 diabetes, and severity of liver ... against HBsAg was rare but linked with severe liver fibrosis and cirrhosis, a study from China found.
- Type 2 Diabetes Risk Increases in Children with Liver Disease
Physicians have long observed a relationship between NAFLD and type 2 diabetes ... [1.0-3.0]), and more severe liver histology including steatosis grade (HR 1.3 [ 1.0-1.7]), and fibrosis stage ...